Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by PutinKhuylo1on Dec 30, 2017 12:40pm

102 Views

Post# 27251324

RE:Howard; you have some explaining to do

That's the way I read it. If true, we're about to begin Phase I and yet another milestone payment. I guess management has decided to underpromise and overdeliver. I'm just guessing, but I'm thinking they were waiting for the check and the CFDA acceptance beat them and the check to the punch. LOL, no good deed goes unpunished. It's huge news really.

Bullboard Posts

Why this low-cost natural gas stock is missing in your portfolio